CancerConnect News According to an Italian research team the three aromatase inhibitors approved for the treatment of postmenopausal hormone receptorpositive early stage breast cancer have no significant differences in effectiveness or safety For the stud [...]
CancerConnect News The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with pancreatic cancer will continue to enroll patients based onThe Data Monitoring Committee first interim analy [...]
Younger patients with non-small cell lung cancer NSCLC are more likely to receive treatment than older patients regardless of overall health and prognosis according to the results of a study published in the Journal of Clinical Oncology Lung cancer remain [...]
CancerConnect News Epidermal Growth Factor Receptor EGFR inhibitor drugs are a type of precision cancer medicine commonly used to treat lung colon head and neck and other cancers that over express the EGFR There are several EGFR inhibitor drugs and these [...]
CancerConnect News Rubraca rucaparib has been approved for the maintenance treatment of adult patients with recurrent epithelial ovarian fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy B [...]
CancerConnect News Metastatic melanoma patients with the BRAF V600 mutation treated with the combination of Tafinlardabrafenib Mekinisttrametinib can experience long term cancer free survival according to results presented at the 53rdAnnual Meeting of th [...]
CancerConnect News Combination therapy with Afinitor everolimus and Femara letrozole demonstrated encouraging activity in the treatment of advanced endometrial cancer according to a report from the Society of Gynecologic Oncologists meeting this week Abou [...]
CancerConnect News As the month of April brings head and neck cancer into focus its time to increase public understanding of the disease including its prevalence approaches to screening and prevention treatment options and resources that offer updated hea [...]
CancerConnect News The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to enfortumab vedotin for patients with locally advanced or metastatic urothelial bladder cancer who were previously treated with checkpoint inhibitors [...]
Interim results from a randomized clinical trial for patients with desmoid tumors or aggressive fibromatosis DTDF show that the drug Nexavar sorafenib tosylate extended progression-free survival compared with a placebo Progression-free survival is the len [...]
